Comparative study of multidrug-resistant obtained from different hosts Free

Abstract

The possible transfer of antimicrobial resistance genes between isolates from humans and different animal species, including those not covered by monitoring programs (e.g. pet and wildlife), poses a serious threat to public health.

Little is known about occurrence and mechanisms of phenomenon of multidrug resistance of isolated from various host species in Poland.

The aim of the study was to characterize multidrug-resistant isolated from humans and animals (livestock, pets and wildlife) in terms of the occurrence of genetic markers determining resistance.

Bacterial isolates were tested for phenotypic resistance and the presence of genes encoding resistance to macrolides, tetracycline, aminoglycosides, aminocyclitols and phenicols as well as efflux pump (A), resolvase (X) and integrase () genes. The quinolone resistance-determining regions of A and C were sequenced.

Human isolates of were characterized by high-level resistance to: ciprofloxacin, enrofloxacin, erythromycin (100 %), as well, as aminoglycosides resistance (kanamycin – 100%, streptomycin – 78 %, gentamicin – 78%). Regardless of the animal species, high level of resistance of to tetracycline (from 88–100 %), erythromycin (from 82–94 %) and kanamycin (from 36–100 %) was observed. All isolates from wildlife were resistant to fluoroquinolones. However, full susceptibility to vancomycin was observed in all isolates tested. Phenotypic antimicrobial resistance of was identified in the presence of the following resistance genes: (B) (70%), (A) (50 %), (L) (35 %), (K) (34 %), (M) (76 %), (25%), (31%), (68 %), (X) (23 %), and integrase gene () (34 %). A correlation between an amino acid substitution at positions 83 and 87 of A and position 80 of C and the high-level fluoroquinolone resistance in has been observed as well.

The level and range of antimicrobial resistance and the panel of resistance determinants is comparable between isolates, despite host species.

Funding
This study was supported by the:
  • Narodowe Centrum Nauki (Award 2018/02/X/NZ7/ 02853)
    • Principle Award Recipient: AleksandraTrościańczyk
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.001340
2021-03-22
2024-03-28
Loading full text...

Full text loading...

/deliver/fulltext/jmm/70/3/jmm001340.html?itemId=/content/journal/jmm/10.1099/jmm.0.001340&mimeType=html&fmt=ahah

References

  1. Sharma C, Rokana N, Chandra M, Singh BP, Gulhane RD et al. Antimicrobial resistance: its surveillance, impact, and alternative management strategies in dairy animals. Front Vet Sci 2017; 4:237 [View Article][PubMed]
    [Google Scholar]
  2. Miller WR, Munita JM, Arias CA. Mechanisms of antibiotic resistance in enterococci. Expert Rev Anti Infect Ther 2014; 12:1221–1236 [View Article][PubMed]
    [Google Scholar]
  3. De Briyne N, Atkinson J, Pokludová L, Borriello SP. Antibiotics used most commonly to treat animals in Europe. Vet Rec 2014; 175:325 [View Article][PubMed]
    [Google Scholar]
  4. Jia W, Li G, Wang W. Prevalence and antimicrobial resistance of Enterococcus species: a hospital-based study in China. Int J Environ Res Public Health 2014; 11:3424–3442 [View Article][PubMed]
    [Google Scholar]
  5. Palmer KL, Kos VN, Gilmore MS. Horizontal gene transfer and the genomics of enterococcal antibiotic resistance. Curr Opin Microbiol 2010; 13:632–639 [View Article][PubMed]
    [Google Scholar]
  6. DANMAP (Danish Integrated Antimicrobial Resistance Monitoring and Research Programme DANMAP 2019 - Use of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from food animals, food and humans in Denmark; 2020; National Food Institute, Technical University of Denmark. Available from: https://www.danmap.org/-/media/arkiv/projekt-sites/danmap/danmap-reports/danmap-2019/danmap_2019.pdf?la=en .
  7. NARMS (National Antimicrobial Resistance Monitoring System for Enteric Bacteria) Antibiotic resistance threats in the United States, 2019; Atlanta, GA; U.S. Department of Health and Human Services, CDC; 2019. Available from: https://www.cdc.gov/drugresistance/pdf/threats-report/2019-ar-threats-report-508 .
  8. EFSA European Food and Safety Authority) and ECDC (European Centre for Disease Prevention and Control The European Union summary report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2017. EFSA Journal 2019; 17:5598
    [Google Scholar]
  9. Magiorakos A-P, Srinivasan A, Carey RB, Carmeli Y, Falagas ME et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012; 18:268–281 [View Article][PubMed]
    [Google Scholar]
  10. Nowakiewicz A, Ziółkowska G, Trościańczyk A, Zięba P, Gnat S. Determination of resistance and virulence genes in Enterococcus faecalis and E. faecium strains isolated from poultry and their genotypic characterization by ADSRRS-fingerprinting. Poult Sci 2016; 96:1–11
    [Google Scholar]
  11. Nowakiewicz A, Ziółkowska G, Trościańczyk A, Zięba P, Gnat S. Determination of antimicrobial resistance of Enterococcus strains isolated from pigs and their genotypic characterization by method of amplification of DNA fragments surrounding rare restriction sites (ADSRRS fingerprinting). J Med Microbiol 2017; 66:175–183 [View Article][PubMed]
    [Google Scholar]
  12. Nowakiewicz A, Ziółkowska G, Zięba P, Trościańczyk A, Banach T et al. Modified 16S-23S rRNA intergenic region restriction endonuclease analysis for species identification of Enterococcus strains isolated from pigs, compared with identification using classical methods and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. J Med Microbiol 2015; 64:217–223 [View Article][PubMed]
    [Google Scholar]
  13. Clinical and Laboratory Standard Institute Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals; Approved standard-fourth edition, CLSI document Vet 01-S2. Pennsylvania, USA: Wayne; 2013
    [Google Scholar]
  14. Clinical and Laboratory Standard Institute Performance standards for antimicrobial susceptibility testing; twenty fourth informational supplement. (No. 1), CLSI document M100- S24. Pennsylvania, USA: Wayne; 2014
    [Google Scholar]
  15. Leavis HL, Willems RJL, Top J, Bonten MJM. High-level ciprofloxacin resistance from point mutations in gyrA and parC confined to global hospital-adapted clonal lineage CC17 of Enterococcus faecium . J Clin Microbiol 2006; 44:1059–1064 [View Article][PubMed]
    [Google Scholar]
  16. de Regt MJA, van Schaik W, van Luit-Asbroek M, Dekker HAT, van Duijkeren E et al. Hospital and community ampicillin-resistant Enterococcus faecium are evolutionarily closely linked but have diversified through niche adaptation. PLoS One 2012; 7:e30319 [View Article][PubMed]
    [Google Scholar]
  17. Nowakiewicz A, Zięba P, Gnat S, Trościańczyk A, Osińska M et al. A significant number of multi-drug resistant Enterococcus faecalis in wildlife animals; long-term consequences and new or known reservoirs of resistance?. Sci Total Environ 2020; 705:135830 [View Article][PubMed]
    [Google Scholar]
  18. Sieńko A, Wieczorek P, Wieczorek A, Sacha P, Majewski P. Occurrence of high-level aminoglycoside resistance (HLAR) among Enterococcus species strains. Prog Health Sci 2014; 4:179–187
    [Google Scholar]
  19. Nowakiewicz A, Ziółkowska G, Zięba P, Kostruba A. Undomesticated animals as a reservoir of multidrug-resistant Enterococcus in eastern Poland. J Wildl Dis 2014; 50:645–650 [View Article][PubMed]
    [Google Scholar]
  20. Kim YB, Seo KW, Shim JB, Son SH, Noh EB et al. Molecular characterization of antimicrobial-resistant Enterococcus faecalis and Enterococcus faecium isolated from layer parent stock. Poult Sci 2019; 98:5892–5899 [View Article][PubMed]
    [Google Scholar]
  21. European Medicines Agency Reflection paper on use of aminoglycosides in animals in the European Union: development of resistance and impact on human and animal health. European surveillance of veterinary antimicrobial consumption; 2018(EMA/CVMP/AWP/721118/2014)
  22. Ramirez MS, Tolmasky ME. Aminoglycoside modifying enzymes. Drug Resist Updat 2010; 13:151–171 [View Article][PubMed]
    [Google Scholar]
  23. Aslam M, Diarra MS, Checkley S, Bohaychuk V, Masson L. Characterization of antimicrobial resistance and virulence genes in Enterococcus spp. isolated from retail meats in Alberta, Canada. Int J Food Microbiol 2012; 156:222–230 [View Article][PubMed]
    [Google Scholar]
  24. Jahan M, Zhanel GG, Sparling R, Holley RA. Horizontal transfer of antibiotic resistance from Enterococcus faecium of fermented meat origin to clinical isolates of E. faecium and Enterococcus faecalis . Int J Food Microbiol 2015; 199:78–85 [View Article][PubMed]
    [Google Scholar]
  25. Stępień-Pyśniak D, Hauschild T, Dec M, Marek A, Urban-Chmiel R. Clonal structure and antibiotic resistance of Enterococcus spp. from wild birds in Poland. Microb Drug Resist 2019; 25:1227–1237 [View Article][PubMed]
    [Google Scholar]
  26. Zalipour M, Esfahani BN, Havaei SA. Phenotypic and genotypic characterization of glycopeptide, aminoglycoside and macrolide resistance among clinical isolates of Enterococcus faecalis: a multicenter based study. BMC Res Notes 2019; 12:1–8 [View Article]
    [Google Scholar]
  27. Choi J-M, Woo G-J. Transfer of tetracycline resistance genes with aggregation substance in food-borne Enterococcus faecalis . Curr Microbiol 2015; 70:476–484 [View Article][PubMed]
    [Google Scholar]
  28. Hidano A, Yamamoto T, Hayama Y, Muroga N, Kobayashi S et al. Unraveling antimicrobial resistance genes and phenotype patterns among Enterococcus faecalis isolated from retail chicken products in Japan. PLoS One 2015; 10:e0121189 [View Article][PubMed]
    [Google Scholar]
  29. Werner G, Coque TM, Franz CMAP, Grohmann E, Hegstad K et al. Antibiotic resistant enterococci-tales of a drug resistance gene trafficker. Int J Med Microbiol 2013; 303:360–379 [View Article][PubMed]
    [Google Scholar]
  30. Urushibara N, Suzaki K, Kawaguchiya M, Aung MS, Shinagawa M et al. Contribution of type II topoisomerase mutations to fluoroquinolone resistance in Enterococcus faecium from Japanese clinical setting. Microb Drug Resist 2018; 24:1–7 [View Article][PubMed]
    [Google Scholar]
  31. López M, Tenorio C, Del Campo R, Zarazaga M, Torres C. Characterization of the mechanisms of fluoroquinolone resistance in vancomycin-resistant enterococci of different origins. J Chemother 2011; 23:87–91 [View Article][PubMed]
    [Google Scholar]
  32. Sadowy E, Luczkiewicz A. Drug-resistant and hospital-associated Enterococcus faecium from wastewater, riverine estuary and anthropogenically impacted marine catchment basin. BMC Microbiol 2014; 14:66 [View Article][PubMed]
    [Google Scholar]
  33. Fuzi M, Szabo D, Csercsik R. Double-serine fluoroquinolone resistance mutations advance major international clones and lineages of various multi-drug resistant bacteria. Front Microbiol 2017; 8:2261 [View Article][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.001340
Loading
/content/journal/jmm/10.1099/jmm.0.001340
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF

Most cited Most Cited RSS feed